Sexual dysfunction in patients with testicular germ cell tumors after treatment

##plugins.themes.bootstrap3.article.main##

А. В. Сакало

Abstract

Most patients with GCT are at a young, reproductive age, the study of the quality of life and sexual health seems to be important. The frequency of sexual dysfunction was analyzed in 39 patients with GCT in different stages after removal of the primary tumor and chemotherapy treatment (the number of courses ranged from carboplatin monotherapy to 4 courses of PEB). Patients after RPLDE and radiotherapy were not included in the study. Chemotherapy leads to sexual and psychological disorders – after 6 months from removal of the primary tumor a lack of satisfaction with sexual life was noted in 23%, a decrease in libido 17.9%, erectile dysfunction 25.6% and a significant increase in body weight in 28.2%. Direct correlations were found after 6 months from the removal of the primary tumor between the reduction of libido and the following features: the number of courses of chemotherapy, stage of the disease and the histological structure of the tumor. Before the removal of the primary tumor a decrease in libido was observed in 12.8%, in 2 years after – in 10.3%. The increase in body weight can be regarded as a manifestation of the metabolic syndrome, which is often accompanied by hypercholesterolemia and subclinical hypogonadism and enhances the negative impact on the quality of life of patients.

##plugins.themes.bootstrap3.article.details##

How to Cite
Сакало, А. В. (2017). Sexual dysfunction in patients with testicular germ cell tumors after treatment. Health of Man, (3(62), 78–81. https://doi.org/10.30841/2307-5090.3(62).2017.117925
Section
Sexology and andrology
Author Biography

А. В. Сакало, ДУ «Інститут урології НАМН України», м. Київ

A.V. Sakalo

References

Heidenreich A. Quality-of-life issues in the treatment of testicular cancer / А. Heidenreich, R.Hofmann // World J Urol. – 1999. – 17(4). – P. 230–8.

Jonker-Pool G. Sexual functioning after treatment for testicular cancer – Review and meta-analysis of 36 empirical studies between 1975–2000 / G. Jonker-Pool [et al.] // Archives of Sexual Behavior. – 2001. – 30 (1). – P. 55–74.

Jonker-Pool G. Sexual functioning after treatment for testicular cancer comparison of treatment modalities / G. Jonker-Pool, J. van Basten, H. Hoekstra [et al.] // Cancer. – 1997. – 80 (3). – P. 454–64.

Schover L. Sexual dysfunction and infertility as late effects of cancer treatment / L. Schover, M. van der Kaaij, E. van Dorst [et al.] // EJC Suppl. – 2014. – 12 (1). – P. 41–53.

Haugnes H. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study / H. Haugnes, T. Haugnes, N. Aass [et al.] // J Clin Oncol. – 2010.

– 28 (30). – P. 4649–57.

Fung C. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study / C. Fung, S. Fossa, M. Milano [et al.] // J Clin Oncol. – 2015. – 33 (28). – P. 3105–15.

Oleary MP. A Brief Male Sexual Function Inventory for Urology / M.P.Oleary [et al.] // Urology. – 1995. – 46 (5). – P. 697–706.

Tuncel A. Relationship between IIEF score, erection hardness score and beck depression index in the evaluation of erectile dysfunction / A. Tuncel [et al.] // Journal of Sexual Medicine. – 2008. – 5. – P. 108–108.

Seidman SN. Exploring the relationship between depression and erectile dysfunction in aging men / SN.Seidman // Journal of Clinical Psychiatry. – 2002. – 63. – P. 5–12.

Incrocci L. Treatment outcome, body image, and sexual functioning after orchiectomy and radiotherapy for Stage I-II testicular seminoma / L. Incrocci, W. Hop, A. Wijnmaalen [et al.] // Int J Radiat Oncol Biol Phys. – 2002. – 53(5). – P. 1165–73.

Glendenning J. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer / J. Glendenning, Y. Barbachano, A. Norman [et al.] // Cancer. – 2010. – 116 (10). – P. 2322–31.

Wortel R. Orchiectomy and radiotherapy for stage I-II testicular seminoma: a prospective evaluation of short-term effects on body image and sexual function / R. Wortel, G. Alemayehu, L. Incrocci // J Sex Med. – 2015. – 12 (1). – P. 210–8.

Arai Y. Sexuality and fertility in long-term survivors of testicular cancer / Y. Arai // J Clin Oncol. – 1997. – 15 (4). – P. 1444–8.

Rossen P. Sexuality and body image in long-term survivors of testicular cancer / P. Rossen, A. Pedersen, R. Zachariae [et al.] // Eur J Cancer. – 2012. – 48 (4). – P. 571–8.

Capogrosso P. Long-term recovery of normal sexual function in testicular cancer survivors / P. Capogrosso, L. Boeri, M. Ferrari [et al.] // Asian J Androl. – 2014. – 18 (1). – P. 85–9.

Tal R. Erectile dysfunction in men treated for testicular cancer / R. Tal, D. Stember, N. Logmanieh [et al.] // BJU Int. – 2014. – 113 (6). – P. 907–10.

Bussen S. Semen parameters in patients with unilateral testicular cancer compared to patients with other malignancies / S. Bussen, M. Sьtterlin, T. Steck [et al.] // Arch Gynecol Obstet. – 2004. – 269(3). – P. 196–8.

Raman J. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis / J. Raman, C. Nobert // J Urol. – 2005. – 174 (5). – P. 1819–22.